5th annual conference on Cytokines and Inflammation

Authors: Numerof, Robert P; Blasko, Eric

Source: Expert Opinion on Therapeutic Targets, Volume 11, Number 7, July 2007 , pp. 983-987(5)

Buy & download fulltext article:

Price: $99.00 plus tax (Refund Policy)

Abstract:

The concept of anticytokine therapies for the treatment of inflammatory diseases has been proven with the successful launch of therapeutics targeting TNF and IL-1, and with numerous additional anticytokine strategies in development. The 5th annual conference on Cytokines and Inflammation provided a timely update on this topic with sections devoted to cytokine biology, chemokines, new technologies for cytokine-based therapy and small-molecule agonists and antagonists. This brief review summarizes key findings from the conference.

Keywords: cytokine; IL-1; IL-17; inflammation; TNF

Document Type: Research article

DOI: http://dx.doi.org/10.1517/14728222.11.7.983

Affiliations: 1: Inflammation and Immunology Therapeutic Research Group, Bayer HealthCare Pharmaceuticals, 2600 Hilltop Drive, PO Box 4099, Richmond, CA 94804-0099, USA, Email: robert.numerof@bayer.com

Publication date: 2007-07-01

More about this publication?